146
Participants
Start Date
May 14, 2024
Primary Completion Date
November 1, 2025
Study Completion Date
December 31, 2025
Oscillometric intermittent non-invasive blood pressure
The hemodynamic management followed liberal fluid therapy, as determined by the attending anesthetist's discretion
ClearSight
The hemodynamic management will be conducted in accordance to a goal-directed fluid therapy (GDFT) utilizing the Clearsight system monitoring.
RECRUITING
Rossano Festa, Roma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER